Sarda Proteins Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Sarda Proteins Ltd · Outcome · 30 Oct 2026, 11:27 pm
Sarda Proteins Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 81.0 (-81.2% YoY | -93.8% QoQ) ■ EBITDA: 19.0 (-36.7% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 23.4 (+1643 bps YoY | Loss to Profit QoQ) ■ PAT: 14.0 (-65.5% YoY | -91.6% QoQ) ■ EPS (INR): 0.16 (-93.2% YoY | -91.4% QoQ)
Original exchange filing (PDF)
More announcements from Sarda Proteins Ltd
- As Per Attachment · 30 Oct 2026
- Letter of Offer for the Rights issue · 30 Oct 2026
- Board at its meeting held today, i.e. on October 26, 2026, has, inter alia considered, approved and fixed the terms of the rights issue including issue price and Record Date. · 27 Oct 2026
- Fresita Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the Unaudited Standalone Financial .... · 30 Oct 2026
- Fresita Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve matter in connection with .... · 21 Oct 2026
- Scrutinizer''s Report · 02 Oct 2026
- ATTACHED HEREWITH PROCEEDING OF 35TH AGM · 30 Sept 2026
- Clarification of Price Movement · 17 Sept 2026
